{"data":[{"accessionNo":"0001104659-26-015319","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001815974","issuerName":"ANEBULO PHARMACEUTICALS, INC.","ticker":"ANEB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Nantahala Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":3547398,"percentOfClass":8.53,"filedAt":"2026-02-13"},{"accessionNo":"0001104659-26-015319","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001815974","issuerName":"ANEBULO PHARMACEUTICALS, INC.","ticker":"ANEB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wilmot B. Harkey","reportingCik":null,"personType":"HC","sharesOwned":3547398,"percentOfClass":8.53,"filedAt":"2026-02-13"},{"accessionNo":"0001104659-26-015319","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001815974","issuerName":"ANEBULO PHARMACEUTICALS, INC.","ticker":"ANEB","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Daniel Mack","reportingCik":null,"personType":"HC","sharesOwned":3547398,"percentOfClass":8.53,"filedAt":"2026-02-13"}],"updatedAt":"2026-09-19T02:15:34.475Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data"}